Results

Triple-I Blog | Personal Lines Underwriting Results Improve, Reducing Gap With Commercial Lines – Go Health Pro

by

The U.S. property and casualty insurance industry experienced better-than-expected economic and underwriting results in the first half of 2024, according to the latest forecasting report by Triple-I and Milliman.  The report was released during a members-only webinar on Oct. 10. The industry’s estimated net combined ratio of 99.4 represented a 2.3-points year-over-year improvement, with commercial lines … Read more

Zacks Small Cap Research – AI from EVAX Improves Trial Results – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more

Zacks Small Cap Research – FMST: Foremost Enters Uranium Space Through Option Agreement to Acquire up to 70% Interest in 10 Denison Properties; Spin-Out of Winston Gold/Silver Properties; Results of Winter Drilling Program at Zoro Property. – Go Health Pro

by
Zacks Small Cap Research – FMST: Foremost Enters Uranium Space Through Option Agreement to Acquire up to 70% Interest in 10 Denison Properties; Spin-Out of Winston Gold/Silver Properties; Results of Winter Drilling Program at Zoro Property. – Go Health Pro

By Steven Ralston, CFA NASDAQ:FMST | CSE:FAT READ THE FULL FMST RESEARCH REPORT FOREMOST ENTERS THE URANIUM INDUSTRY Foremost Enters the Uranium Exploration Industry Through an Option Agreement with Denison On September 24, 2024, Foremost Lithium (NASDAQ:FMST) (CSE:FAT) announced the signing of an Option Agreement with Denison Mines Corp. (NYSE:DNN (TSX:DML) concerning 10 Uranium Exploration … Read more

Zacks Small Cap Analysis – ARWR: PALISADE Part 3 Outcomes Revealed in NEJM… – Go Well being Professional

by
Zacks Small Cap Analysis – ARWR: PALISADE Part 3 Outcomes Revealed in NEJM… – Go Well being Professional

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Enterprise Replace Part 3 PALISADE Outcomes Revealed in The New England Journal of Drugs On September 2, 2024, Arrowhead Prescribed drugs, Inc. (NASDAQ:ARWR) introduced outcomes for the Part 3 PALISADE trial of plozasiran in sufferers with familial chylomicronemia syndrome (FCS). The outcomes had been … Read more

High Native website positioning Instruments You Must Use for Higher Outcomes – Go Well being Professional

by
High Native website positioning Instruments You Must Use for Higher Outcomes – Go Well being Professional

Generally, companies are frightened about producing natural visitors and staying in search engine marketing however there’s nothing to fret about. All due to native website positioning instruments. The reason being that they’ve the potential to help native on-line companies in driving an enormous natural visitors. Native companies can use native website positioning instruments to drive … Read more

x